User profiles for J. Goike
 | Jule GoikeUniversity of Texas at Austin Verified email at utexas.edu Cited by 572 |
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
The molecular composition and binding epitopes of the immunoglobulin G (IgG) antibodies
that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-…
that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-…
Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
[PDF][PDF] Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA
… (J) Size of R20 glomeruli per kidney section from R3 mice per group. In (A) and (H),
significant differences between Dnase1l3Ā/Ā versus Dnase1l3Ā/ĀCd40lgĀ/Ā mice are shown. …
significant differences between Dnase1l3Ā/Ā versus Dnase1l3Ā/ĀCd40lgĀ/Ā mice are shown. …
Electrosurgical management of Hunner ulcers in a referral center's interstitial cystitis population
A Chennamsetty, I Khourdaji, J Goike, KA Killinger… - Urology, 2015 - Elsevier
Objective To characterize electrocautery (EC) as a valid treatment option in interstitial cystitis
(IC) patients with Hunner ulcers (HUs). Methods From 1997 to 2013, a single urologist's IC …
(IC) patients with Hunner ulcers (HUs). Methods From 1997 to 2013, a single urologist's IC …
[PDF][PDF] Rapid characterization of spike variants via mammalian cell surface display
The SARS-CoV-2 spike protein is a critical component of vaccines and a target for neutralizing
monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with …
monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with …
[HTML][HTML] SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode
… Our methods proceed through antibody V(D)J annotation of raw MinION reads using MiXCR
(v3.0.13) ; iteratively growing and shrinking sequence clusters based on annotated features …
(v3.0.13) ; iteratively growing and shrinking sequence clusters based on annotated features …
[PDF][PDF] Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area. mBio 11: e02707-20
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
strains causing two coronavirus disease 2019 (COVID-19) disease waves in …
[HTML][HTML] Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding …
J Goike, CL Hsieh, A Horton, EC Gardner, F Bartzoka… - Biorxiv, 2021 - ncbi.nlm.nih.gov
The ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious variants
has sparked concern over the continued effectiveness of existing therapeutic antibodies …
has sparked concern over the continued effectiveness of existing therapeutic antibodies …
Clinical utility of cytokeratins as tumor markers
V Barak, H Goike, KW Panaretakis, R Einarsson - Clinical biochemistry, 2004 - Elsevier
Cytokeratins, belonging to the intermediate filament (IF) protein family, are particularly useful
tools in oncology diagnostics. At present, more than 20 different cytokeratins have been …
tools in oncology diagnostics. At present, more than 20 different cytokeratins have been …
[HTML][HTML] Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America
…, H Goike, H Gandhi, JC Korevaar, J Tkacz… - The Journal of Allergy …, 2022 - Elsevier
Background Expert national/global asthma management recommendations raise the issue
whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant …
whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant …